Samuel Mercer has over 25 years of global pharmaceutical development experience, previously managing external agreements and outsourcing in the areas of multinational clinical trials, IT and scientific consulting, academic alliances, and pharma licensing, and negotiating directly over USD 600 million in varied external agreements for both Roche and Novartis in Basel, Switzerland. Prior to this, he managed proposals, contracts, and business development at several global contract research organizations in the UK and US. More recently, he is a management consultant, interim executive, board member, and advisor to a number of biotechnology and software/tech startups. His focus is on technology and IP development, clinical trial strategy, financial modelling, startup-company strategy and funding, and negotiating and managing of complex business agreements.
